Trial Profile
Pharmacogenetic Clinical Trial of Nepicastat for PTSD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Oct 2021
Price :
$35
*
At a glance
- Drugs Nepicastat (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors Synosia Therapeutics
- 08 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jul 2009 Planned end date changed from Jan 2009 to Nov 2009 as reported by ClinicalTrials.gov.
- 10 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.